First results from the collaboration between CHU Caen Normandie and Resolve Stroke officially presented at the SFAR meeting (French Society of Anaesthesia and Intensive Care), sparking great interest within the community.
First Patients enrolled in clinical trial using Resolve Stroke’s SYLVER Platform
Resolve Stroke has enrolled the first patients in a groundbreaking clinical trial using its #SYLVER platform to evaluate transcranial ultrasound data for detecting cerebral hypoperfusion in neurocritical care units. This significant milestone brings us closer to revolutionizing the application of ultrasound in neurology, much like the transformative journey of cardiac ultrasound years ago.